ZYUS Life Sciences Balance Sheet Health
Financial Health criteria checks 2/6
ZYUS Life Sciences has a total shareholder equity of CA$15.5M and total debt of CA$7.3M, which brings its debt-to-equity ratio to 46.8%. Its total assets and total liabilities are CA$35.8M and CA$20.3M respectively.
Key information
46.8%
Debt to equity ratio
CA$7.26m
Debt
| Interest coverage ratio | n/a |
| Cash | CA$836.00k |
| Equity | CA$15.53m |
| Total liabilities | CA$20.26m |
| Total assets | CA$35.79m |
Recent financial health updates
Financial Position Analysis
Short Term Liabilities: ZYUS's short term assets (CA$4.4M) do not cover its short term liabilities (CA$15.1M).
Long Term Liabilities: ZYUS's short term assets (CA$4.4M) do not cover its long term liabilities (CA$5.2M).
Debt to Equity History and Analysis
Debt Level: ZYUS's net debt to equity ratio (41.4%) is considered high.
Reducing Debt: Insufficient data to determine if ZYUS's debt to equity ratio has reduced over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: ZYUS has sufficient cash runway for 1 months based on last reported free cash flow, but has since raised additional capital.
Forecast Cash Runway: ZYUS is forecast to have sufficient cash runway for 1 months based on free cash flow estimates, but has since raised additional capital.